Positive Phase 3 Trial in hATTR Amyloidosis With Polyneuropathy ...Middle East

The RNAi therapeutic vutrisiran met its primary and secondary endpoints in the HELIOS-A phase 3 study of patients with hereditary transthyretin-mediated amyloidosis with polyneuropathy. Medscape Medical News

Read More Details
Finally We wish PressBee provided you with enough information of ( Positive Phase 3 Trial in hATTR Amyloidosis With Polyneuropathy )

Also on site :

• De Anza College physical education complex to undergo $53 million renovation
• Rodeo man charged with kidnapping in East Bay home invasions
• Free People’s Viral Barrel Jeans Have the Internet Divided Over Their Stylishness (and They’re Almost Out of Stock)